Fundació Renal Jaume Arnó Report issue

Foundation Phase 4

Organization Overview

First Clinical Trial
2012
NCT02372695
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Fundació Renal Jaume Arnó